Rinat Neuroscience
A leader in the development of therapeutic antibodies.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD218—327m (Dealroom.co estimates Aug 2003.)
Palo Alto California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $17.5m | Series A | |
$40.0m | Series B | ||
| N/A | N/A | - | |
N/A | Acquisition | ||
| Total Funding | CAD78.4m | ||